A promising early intervention treatment for cerebral palsy in newborn babies has proven effective in both boys and girls – even though it works differently depending on the sex of the offspring.
When babies are deprived of oxygen during pregnancy or birth it can cause long-term motor impairment and poor neurological outcomes, leading to conditions such as cerebral palsy.
This study investigated the effectiveness of umbilical cord blood (UCB) stem cells as a potential early intervention therapy for perinatal brain injuries caused by lack of oxygen.
Differences between sexes
The team, led by Dr Tayla Penny at Hudson Institute of Medical Research, demonstrated that UCB cell therapy improved outcomes in both males and females, and showed for the first time that there may be differences between sexes in the way the cells reduce injury.
“Males are more susceptible to perinatal brain injury, and account for up to 58 per cent of cerebral palsy cases in Australia,” Dr Penny said.
“Due to this, it is important that the effectiveness of novel treatments for cerebral palsy are tested in both males and females and any differences are characterised.”
Improved treatment in males and females
“In this study we found that UCB cell therapy improved outcomes in both males and females, however there appear to be differences in the way that the cells reduce brain injury between sexes.
“The results of this study will provide confidence that umbilical cord blood cell therapy is an appropriate treatment for both males and females as we move forward with clinical translation,” Dr Penny said.
Hudson Institute communications
t: + 61 3 8572 2697
